Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

657
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
657

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysregulation of IL-37/SIGIRR Axis in De Novo acute myeloid leukemia patients: association with treatment response.

Molecular biology reports·2026
Same author

Choosing the Right Extracellular Vesicle: Cross-Kingdom Immunological Functions Linking Molecular Mechanisms to Therapeutic Applications.

Biomolecules·2026
Same author

A non-conjugated peptide-adjuvant system of synthetic peptide-vaccine elicited potent antibody response and opsonic protection against clinical GAS strains.

Bioorganic chemistry·2026
Same author

Rational selection of antigenic targets for Group A Streptococcus vaccine: updates, challenges and opportunities.

NPJ vaccines·2026
Same author

Veterinary Forensic Pathology in the Investigation of Animal Cruelty: Post-Mortem Insights, Forensic Tools, Case Studies, and Legal Perspectives.

Animals : an open access journal from MDPI·2026
Same author

The Collaborative Collapse: Bile Acid Dysmetabolism as a Central Pathogenic Driver in Canine and Feline Multi-Systemic Disorders-From Mechanisms to Precision Therapeutics.

Veterinary sciences·2026

Related Experiment Video

Updated: Oct 9, 2025

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.1K

Developing an Effective Glycan-Based Vaccine for Streptococcus Pyogenes.

Asmaa Mahmoud1, Istvan Toth2,3,4, Rachel Stephenson1

  • 1School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Australia.

Angewandte Chemie (International Ed. in English)
|December 22, 2021
PubMed
Summary
This summary is machine-generated.

Developing carbohydrate-based vaccines against Streptococcus pyogenes offers a promising strategy to combat millions of annual infections. This review explores reverse vaccinology and antigen production methods to overcome challenges in creating effective vaccines.

Keywords:
glycoconjugatesglycopeptidesimmunochemistryoligosaccharidesstructure-activity relationships

More Related Videos

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

12.6K
High-throughput Synthesis of Carbohydrates and Functionalization of Polyanhydride Nanoparticles
14:37

High-throughput Synthesis of Carbohydrates and Functionalization of Polyanhydride Nanoparticles

Published on: July 6, 2012

11.6K

Related Experiment Videos

Last Updated: Oct 9, 2025

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.1K
Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

12.6K
High-throughput Synthesis of Carbohydrates and Functionalization of Polyanhydride Nanoparticles
14:37

High-throughput Synthesis of Carbohydrates and Functionalization of Polyanhydride Nanoparticles

Published on: July 6, 2012

11.6K

Area of Science:

  • Microbiology and Immunology
  • Vaccine Development

Background:

  • Streptococcus pyogenes causes significant global morbidity and mortality, necessitating effective preventative measures.
  • Carbohydrate-based subunit vaccines are promising due to unique bacterial glycan patterns and conserved serotypes.

Purpose of the Study:

  • To review the application of reverse vaccinology in developing Streptococcus pyogenes subunit vaccines.
  • To highlight reproducible methods for carbohydrate antigen production and structure-immunogenicity correlations.
  • To discuss recent advancements in overcoming challenges in carbohydrate-based vaccine development.

Main Methods:

  • Review of reverse vaccinology principles applied to S. pyogenes vaccine design.
  • Analysis of reproducible carbohydrate antigen production techniques.
  • Examination of structure-immunogenicity relationships for group A carbohydrate epitopes and carrier systems.

Main Results:

  • Identification of reverse vaccinology as a viable approach for S. pyogenes vaccine development.
  • Demonstration of reproducible methods for producing key carbohydrate antigens.
  • Correlation established between carbohydrate epitope structure, carrier systems, and immunogenicity.

Conclusions:

  • Carbohydrate-based subunit vaccines, developed using reverse vaccinology, represent a viable strategy against Streptococcus pyogenes.
  • Advances in antigen production and understanding structure-immunogenicity correlations are crucial for successful vaccine design.